Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Luke Moore and Gary Davies.
Luke Moore
Connection Strength
1.324
Gary Davies
  1. Pooled sputum to optimise the efficiency and utility of rapid, point-of-care molecular SARS-CoV-2 testing. BMC Infect Dis. 2021 Jul 08; 21(1):665.
    View in: PubMed
    Score: 0.239
  2. Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection. Lancet Infect Dis. 2021 05; 21(5):598-599.
    View in: PubMed
    Score: 0.231
  3. Comparison of deep learning with regression analysis in creating predictive models for SARS-CoV-2 outcomes. BMC Med Inform Decis Mak. 2020 11 19; 20(1):299.
    View in: PubMed
    Score: 0.229
  4. Serological assays for delayed SARS-CoV-2 case identification - Author's reply. Lancet Respir Med. 2020 10; 8(10):e74.
    View in: PubMed
    Score: 0.226
  5. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study. Lancet Respir Med. 2020 09; 8(9):885-894.
    View in: PubMed
    Score: 0.223
  6. Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis. J Infect. 2021 10; 83(4):452-457.
    View in: PubMed
    Score: 0.060
  7. Association between SARS-CoV-2 exposure and antibody status among healthcare workers in two London hospitals: a cross-sectional study. Infect Prev Pract. 2021 Sep; 3(3):100157.
    View in: PubMed
    Score: 0.060
  8. Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care population. PLoS One. 2020; 15(10):e0240960.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.